Skip to main content
Activity in cell culture
Helmholtz Munich | Stefanie Winkler

Translational Diabetology

My research group is driven by a curiosity to understand how early-stage type 2 diabetes develops at the molecular level and what this can tell us about potential new therapeutic approaches. The investigation of different plasma membrane transporters as target structures for therapeutic interventions in diabetes, obesity and metabolic-associated fatty liver disease are exemplary studies on this topic.  

We are also interested in the hormonal regulation of metabolism and how this influences the ageing process.

We conduct preclinical and clinical studies in the clinical study center.

My research group is driven by a curiosity to understand how early-stage type 2 diabetes develops at the molecular level and what this can tell us about potential new therapeutic approaches. The investigation of different plasma membrane transporters as target structures for therapeutic interventions in diabetes, obesity and metabolic-associated fatty liver disease are exemplary studies on this topic.  

We are also interested in the hormonal regulation of metabolism and how this influences the ageing process.

We conduct preclinical and clinical studies in the clinical study center.

Primary Investigators

Prof. Dr. Andreas Birkenfeld

Director

Rainer_Jumpertz_v_S_Med_Mitarbeiter_ 47

Prof. Dr. Reiner Jumpertz-von Schwartzenberg

Group Leader, Physician Scientist